Table 4.
Baseline (Visit 2) | End of period 1 | End of period 2 | |
---|---|---|---|
FBG (before breakfast) in mmol/L, mean ± SD | |||
Sequence A | 9.24 ± 2.23 | 6.48 ± 1.66 | 6.27 ± 1.32 |
Sequence B | 9.50 ± 2.16 | 6.60 ± 1.82 | 6.15 ± 1.42 |
p-value* | 0.55 | 0.46 | |
Daily insulin doses in U, mean ± SD | |||
Sequence A | 0 | 24.9 ± 20.3 | 28.7 ± 20.1 |
Sequence B | 0 | 24.8 ± 15.7 | 26.0 ± 17.0 |
p-value* | 0.96 | 0.21 | |
Insulin doses by bodyweight in U/kg, mean ± SD | |||
Sequence A | 0 | 0.27 ± 0.20 | 0.31 ± 0.21 |
Sequence B | 0 | 0.27 ± 0.15 | 0.28 ± 0.16 |
p-value* | 0.88 | 0.13 |
Legend: * Unpaired t-test was applied for comparison of treatments in periods; Sequence A: starting with insulin glargine and then switching to NPH insulin; Sequence B: starting with NPH insulin and then switching to insulin glargine